Monitor first-quarter fiscal 2027 earnings on November 2, 2026 for any strategic commentary from the outgoing CEO and CFO that may signal near-term performance trends ahead of the leadership change.
Price Chart
Executive Summary
Clorox appointed Fabian Garcia as CEO, effective January 5, 2027, succeeding Linda Rendle who is stepping down for health reasons. The CEO transition is orderly with a named successor and an advisory period for the outgoing CEO, making this a routine leadership change with no financial impact.
Key Facts
- Fabian Garcia appointed CEO and Board member, effective January 5, 2027
- Linda Rendle steps down as CEO and Chair on that date, serves as senior advisor through April 2, 2027
- Matthew Shattock becomes Independent Chair, receiving a $225,000 retainer
- Garcia's compensation includes $100,000 base salary, $2,000,000 target annual bonus, $4,550,000 pro-rated LTI, and $11,000,000 sign-on RSUs
- Rendle's departure was announced in May 2026 for health reasons; transition is planned and orderly
Financial Impact
No material financial impact; CEO compensation disclosed but within normal ranges for a company of this size ($10.6B market cap)
Risk Factors
- New CEO has not yet led the company; execution risk during transition period through April 2027
- No financial guidance or preliminary results provided in this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001206774-26-000586 |
| Document: clx4708451-ex991.htm | 0001206774-26-000586 |
| Document: 0001206774-26-000586-index-headers.html | 0001206774-26-000586 |
| Document: 0001206774-26-000586-index.html | 0001206774-26-000586 |
| Document: 0001206774-26-000586.txt | 0001206774-26-000586 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 29, 2026 3d ago | DEFA14A | $88.67 | awaiting T+5 | awaiting T+5 | $88.00 (−0.76%) |
Oct 29, 2026 3d ago | 8-K | $88.67 | awaiting T+5 | awaiting T+5 | $88.00 (−0.76%) |
Oct 27, 2026 5d ago | SC 13G/A | $86.84 | awaiting T+5 | awaiting T+5 | $88.00 (+1.34%) |
Oct 16, 2026 16d ago | Institutional Cluster | $85.56 $86.35 | ▲ +0.92% | ▲ +1.06% | $88.00 (+2.85%) |
Oct 7, 2026 25d ago | DEFA14A | $83.44 $86.20 | ▲ +3.31% | ▲ +3.58% | $88.00 (+5.47%) |
Oct 7, 2026 25d ago | DEF 14A | $83.44 $86.20 | ▼ −3.31% | ▼ −3.58% | $88.00 (−5.47%) |
Sep 23, 2026 5w ago | Press Release | $81.80 $80.65 | ▼ −1.41% | ▼ −0.99% | $88.00 (+7.58%) |
Aug 26, 2026 9w ago | Institutional Cluster | $104.23 $94.27 | ▼ −9.56% | ▼ −9.44% | $88.00 (−15.57%) |
Aug 3, 2026 12w ago | Press Release | $104.67 $108.25 | ▲ +3.42% | ▲ +3.52% | $88.00 (−15.93%) |
Jul 13, 2026 15w ago | Press Release | $94.75 | awaiting T+5 | awaiting T+5 | $88.00 (−7.12%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers